Contemporary Trends in Urothelial Cancer Management
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Urology & Nephrology".
Deadline for manuscript submissions: 15 April 2025 | Viewed by 163
Special Issue Editors
Interests: robotic surgery; BPH; cancer; urinary lithiasis
Special Issue Information
Dear Colleagues,
In the past few years, great progress has been made in urothelial carcinoma diagnosis and treatment options, a disease which is diagnosed in more than half a million people every year.
With the advancements in robotic surgery for the treatment of muscle-invasive bladder cancer and upper-tract urothelial carcinoma, there has been a significant decrease in patient morbidity and mortality, with improvements in the quality of life.
Furthermore, novel trials have incorporated immunotherapy with immune checkpoint inhibitors in high-risk and high-grade non-muscle-invasive urothelial carcinoma, while, in metastatic disease, targeted treatments and understanding the genomic landscape have increased the options available in an oncologist’s armamentarium.
This Special Issue aims to present and evaluate new progress in urothelial carcinoma diagnosis and treatment. Articles associated but not limited to the following topics are welcome: new modalities in the diagnosis of bladder cancer and upper-tract urothelial carcinoma and novel treatment options for localized and metastatic urothelial carcinoma.
Authors are invited to share their experience and submit original studies, case series and reports, or review articles to feature in the “Contemporary Trends in Urothelial Cancer Management” Special Issue.
Dr. Panagiotis Mourmouris
Guest Editor
Dr. Nikolaos Kostakopoulos
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bladder cancer
- upper-tract urinary carcinoma
- radical cystectomy
- radical nephroureterectomy
- immunotherapy
- metastatic urothelial carcinoma
- robotic surgery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
